XML 31 R15.htm IDEA: XBRL DOCUMENT v3.26.1

Accrued Expenses and Other Current Liabilities

12 Months Ended

Dec. 31, 2025

Accrued Expenses and Other Current Liabilities

Accrued Expenses and Other Current Liabilities

Note 8 – Accrued Expenses and Other Current Liabilities

As of December 31, 2025 and 2024, accrued expenses and other current liabilities consisted of the following:

​

​	​	​	​	​	​	​
​	​	December 31,
​	​ ​ ​	2025		​ ​ ​	2024
Accrued dividend	​	$	792,616	​	$	—
Accrued rework of clinical supply returns		​	250,000		​	250,000
Accrued franchise tax		​	193,052		​	—
Accrued compensation expense	​	​	190,709	​	​	144,161
Accrued research and development expenses		​	176,948		​	302,880
Accrued professional services	​	​	157,770	​	​	111,750
Accrued foreign tax	​	​	100,000	​	​	295,711
Other accrued expenses	​	​	10,011	​	​	218,172
Total accrued expenses and other current liabilities	​	$	1,871,106	​	$	1,322,674

​

X

- Definition

The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 720
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483384/720-30-45-1

+ Details

Name:	us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration